Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

128 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Serum CGRP in migraine patients using erenumab as preventive treatment.
de Vries Lentsch S, Garrelds IM, Danser AHJ, Terwindt GM, MaassenVanDenBrink A. de Vries Lentsch S, et al. Among authors: maassenvandenbrink a. J Headache Pain. 2022 Sep 12;23(1):120. doi: 10.1186/s10194-022-01483-z. J Headache Pain. 2022. PMID: 36089587 Free PMC article.
Trigeminovascular effects of propranolol in men and women, role for sex steroids.
Rubio-Beltrán E, Schoon RM, van den Berg J, Schuiling-Veninga CCM, Koch BCP, Villalón CM, Versmissen J, Danser AHJ, van den Meiracker AH, Ibrahimi K, MaassenVanDenBrink A. Rubio-Beltrán E, et al. Among authors: maassenvandenbrink a. Ann Clin Transl Neurol. 2022 Sep;9(9):1405-1416. doi: 10.1002/acn3.51640. Epub 2022 Aug 27. Ann Clin Transl Neurol. 2022. PMID: 36029132 Free PMC article. Clinical Trial.
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.
Sacco S, Amin FM, Ashina M, Bendtsen L, Deligianni CI, Gil-Gouveia R, Katsarava Z, MaassenVanDenBrink A, Martelletti P, Mitsikostas DD, Ornello R, Reuter U, Sanchez-Del-Rio M, Sinclair AJ, Terwindt G, Uluduz D, Versijpt J, Lampl C. Sacco S, et al. Among authors: maassenvandenbrink a. J Headache Pain. 2022 Jun 11;23(1):67. doi: 10.1186/s10194-022-01431-x. J Headache Pain. 2022. PMID: 35690723 Free PMC article. Review.
Neurogenic inflammation as a novel treatment target for chronic pain syndromes.
Seidel MF, Hügle T, Morlion B, Koltzenburg M, Chapman V, MaassenVanDenBrink A, Lane NE, Perrot S, Zieglgänsberger W. Seidel MF, et al. Among authors: maassenvandenbrink a. Exp Neurol. 2022 Oct;356:114108. doi: 10.1016/j.expneurol.2022.114108. Epub 2022 May 10. Exp Neurol. 2022. PMID: 35551902 Review.
Validation of diagnostic ICHD-3 criteria for menstrual migraine.
Verhagen IE, Spaink HA, van der Arend BW, van Casteren DS, MaassenVanDenBrink A, Terwindt GM. Verhagen IE, et al. Among authors: maassenvandenbrink a. Cephalalgia. 2022 Oct;42(11-12):1184-1193. doi: 10.1177/03331024221099031. Epub 2022 May 6. Cephalalgia. 2022. PMID: 35514214 Free PMC article.
CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab.
de Vries Lentsch S, Al-Hassany L, Ferrari MD, Terwindt GM, MaassenVanDenBrink A. de Vries Lentsch S, et al. Among authors: maassenvandenbrink a. J Neurol Neurosurg Psychiatry. 2022 Aug;93(8):911-912. doi: 10.1136/jnnp-2021-327992. Epub 2022 Jan 27. J Neurol Neurosurg Psychiatry. 2022. PMID: 35086941 No abstract available.
Sex Differences in Risk Profile, Stroke Cause and Outcome in Ischemic Stroke Patients With and Without Migraine.
Linstra KM, van Os HJA, Ruigrok YM, Nederkoorn PJ, van Dijk EJ, Kappelle LJ, Koudstaal PJ, Visser MC, Ferrari MD, MaassenVanDenBrink A, Terwindt GM, Wermer MJH. Linstra KM, et al. Among authors: maassenvandenbrink a. Front Neurosci. 2021 Nov 3;15:740639. doi: 10.3389/fnins.2021.740639. eCollection 2021. Front Neurosci. 2021. PMID: 34803586 Free PMC article.
128 results